Finally, as fibroblastic FAK activity in human PDAC tumours is an independent prognostic factor for DFS and OS, and mortality is mostly from metastatic disease (Siegel et al, 2017), we assessed the possible impact of fibroblastic FAK activity on tumour metastasis. This evidence concerns the gene PTK2 and metastatic neoplasm.